medigraphic.com

2023, Number 2

<< Back Next >>

Rev Mex Anest 2023; 46 (2)

Efficacy and safety of multimodal intrathecal anesthesia with fentanyl in cesarean section: clinical trial

Alba-Valverde RA, Aguilar-González CL, Paque-Bautista C, González AP, Sosa-Bustamante GP

Language: Spanish
References: 24
Page: 93-97
PDF size: 306.00 Kb.


ABSTRACT

Introduction: fentanyl offers good anesthetic efficacy and fewer effects on the sympathetic nervous system with better hemodynamic status, but its effect in combination with other anesthetics in pregnant women has not been fully described. Objective: to evaluate the anesthetic efficacy and safety of multimodal anesthesia with fentanyl in pregnant women undergoing caesarean section. Material and methods: controlled, randomized, double blinded clinical trial; in pregnant women scheduled for cesarean section distributed in 3 groups: FBMD group: fentanyl 70 μg + hyperbaric bupivacaine 0.1%, 2 mg, + morphine 100 μg + dexmedetomidine 5 μg; BFM group: hyperbaric bupivaine 0.25%, 5 mg, + fentanyl 25 μg + morphine 100 μg, and group BM: hyperbaric bupivacaine 0.375%, 7.5 mg, + morphine 100 μg. The anesthetic efficacy was evaluated: prior to the incision, during the dissection of the abdominal wall, upon entry to the abdominal cavity, in the revision of parietocolic slides and in the immediate postoperative period, as well as the vital signs. Results: 180 women were analyzed. The FBMD group showed greater anesthetic efficacy in the revision of parietocolic slides (p = 0.01) and in the immediate postoperative period (p = 0.0001) and greater safety, showing better hemodynamic control at minutes 1 and 10 (p = 0.02 y p = 0.03 respectively). Conclusions: multimodal anesthesia with FMBD shows better anesthetic efficacy and safety over hemodynamic control.


REFERENCES

  1. Chooi C, Cox JJ, Lumb RS, Middleton P, Chemali M, Emmett RS, et al. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database Syst Rev. 2020;7:CD002251. doi: 10.1002/14651858.CD002251.pub4.

  2. Mercier FJ, Augè M, Hoffmann C, Fischer C, Le Gouez A. Maternal hypotension during spinal anesthesia for caesarean delivery. Minerva Anestesiol. 2013;79:62-73.

  3. Prajith KR, Mishra G, Ravishankar M, Hemanth Kumar VR. Hemodynamic changes under spinal anesthesia after elastic wrapping or pneumatic compression of lower limbs in elective cesarean section: a randomized control trial. J Anaesthesiol Clin Pharmacol. 2020;36:244-250. doi: 10.4103/joacp.JOACP_72_18.

  4. Mugabure B. Factores clave que afectan la biodisponibilidad de los opioides sobre la médula espinal en el manejo del dolor agudo. Rev Soc Esp Dolor. 2019;26:359-367.

  5. Bernards CM, Shen DD, Sterling ES, Adkins JE, Risler L, Phillips B, et al. Epidural, cerebrospinal fluid, and plasma pharmacokinetics of epidural opioids (part 1): differences among opioids. Anesthesiology. 2003;99:455-465. doi: 10.1097/00000542-200308000-00029.

  6. Ummenhofer WC, Arends RH, Shen DD, Bernards CM. Comparative spinal distribution and clearance kinetics of intrathecally administered morphine, fentanyl, alfentanil, and sufentanil. Anesthesiology. 2000;92:739-753. doi: 10.1097/00000542-200003000-00018.

  7. Bernards CM. Understanding the physiology and pharmacology of epidural and intrathecal opioids. Best Pract Res Clin Anaesthesiol. 2002;16:489-505. doi: 10.1053/bean.2002.0255.

  8. Von Cube B, Teschemacher H, Herz A, Hess R. Permeation morphinartig wirksamer Substanzen an den Ort der antinociceptiven Wirkung im Gehirn in Abhängigkeit von ihrer Lipoidloslichkeit nach intravenoser und nach intraventrikularer Applikation [Permeation of active morphine-like substances at their sites of antinociceptive action in the brain as a function of their lipid-solubility following intravenous and intraventricular application]. Naunyn Schmiedebergs Arch Pharmakol. 1970;265:455-473.

  9. Bernards CM. Recent insights into the pharmacokinetics of spinal opioids and the relevance to opioid selection. Curr Opin Anaesthesiol. 2004;17:441-447. doi: 10.1097/00001503-200410000-00015.

  10. Bujedo BM. Spinal opioid bioavailability in postoperative pain. Pain Pract. 2014;14:350-364. doi: 10.1111/papr.12099.

  11. Hindle A, MB ChB, BSc (Hons), DA, FRCA. Intrathecal opioids in the management of acute postoperative pain. Continuing Education in Anesthesia Critical Care and Pain. 2008;8:81-85.

  12. Belzarena SD. Clinical effects of intrathecally administered fentanyl in patients undergoing cesarean section. Anesth Analg. 1992;74:653-657. doi: 10.1213/00000539-199205000-00006.

  13. Choi DH, Ahn HJ, Kim MH. Bupivacaine-sparing effect of fentanyl in spinal anesthesia for cesarean delivery. Reg Anesth Pain Med. 2000;25:240-245. doi: 10.1016/s1098-7339(00)90005-1.

  14. Aragon MC, Calderón E, Pernia A, Vidal M, Torres LM. Analgesia perioperatoria en cesárea: eficacia y seguridad del fentanilo intratecal. Rev Soc Esp Dolor. 2004;11:30-35.

  15. Gaiser RR, Cheek TG, Gutsche BB. Comparison of three different doses of intrathecal fentanyl and sufentanil for labor analgesia. J Clin Anesth. 1998;10:488-493. doi: 10.1016/s0952-8180(98)00076-2.

  16. Manouchehrian N, Rabiei S, Moradi A, Lakpur Z. Comparison of intrathecal injection of fentanyl and sufentanil on the onset, duration, and quality of analgesia in labor: a randomized, double-blind clinical trial. Anesth Pain Med. 2020;10:e99843. doi: 10.5812/aapm.99843

  17. Salgueiro C, Moreno M, Arthagnan C, Peleritti H, Rempel J. Bajas dosis de bupivacaína asociada a fentanilo en anestesia espinal. Técnicas de Anestesia Neuroaxial. 2007;65:401-408.

  18. Piñón K, Valladares M, Correa M, Pozo JA, de la Paz C. Fentanyl-bupivacapína y bupivacaína en intervenciones quirúrgicas. Rev Mex Anest. 2020;43:29-33. doi: 10.35366/CMA201E.

  19. Ali MA, Ismail S, Sohaib M, Aman A. A double-blind randomized control trial to compare the effect of varying doses of intrathecal fentanyl on clinical efficacy and side effects in parturients undergoing cesarean section. J Anaesthesiol Clin Pharmacol. 2018;34:221-226. doi: 10.4103/joacp.JOACP_271_16.

  20. Poma S, Bossi C, Scudeller L, Broglia F, Baldi C, Ciceri M, et al. Hyperbaric bupivacaine and sufentanil for spinal anaesthesia in caesarean section: a cohort study. J Clin Anesth. 2020;62:109706. doi: 10.1016/j.jclinane.2020.109706.

  21. Sibilla C, Albertazz P, Zatelli R, Martinello R. Perioperative analgesia for caesarean section: comparison of intrathecal morphine and fentanyl alone or in combination. Int J Obstet Anesth. 1997;6:43-48. doi: 10.1016/s0959-289x(97)80051-9.

  22. Shah OM, Bhat KM. Comparison of the efficacy and safety of morphine and fentanyl as adjuvants to bupivacaine in providing operative anesthesia and postoperative analgesia in subumblical surgeries using combined spinal epidural technique. Anesth Essays Res. 2017;11:913-920. doi: 10.4103/aer.AER_99_17.

  23. Xia F, Chang X, Zhang Y, Wang L, Xiao F. The effect of intrathecal dexmedetomidine on the dose requirement of hyperbaric bupivacaine in spinal anesthesia for caesarean section: a prospective, double-blinded, randomized study. BMC Anesthesiol. 2018;18:74. doi: 10.1186/s12871-018-0528-2.

  24. Li XX, Li YM, Lv XL, Wang XH, Liu S. The efficacy and safety of intrathecal dexmedetomidine for parturients undergoing cesarean section: a double-blind randomized controlled trial. BMC Anesthesiol. 2020;20:190. doi: 10.1186/s12871-020-01109-4.




2020     |     www.medigraphic.com